© 2022 MJH Life Sciences and CGTLive™. All rights reserved.
© 2022 MJH Life Sciences™ and CGTLive™. All rights reserved.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Data from the first 3 of the 8 patients dosed indicates that the patients improved on the GMFM and the MSEL.
Solid has also pivoted from developing SGT-001 to SGT-003 for treating Duchene muscular dystrophy.